Ketamine Intervention and Treatment-Resistant Depression

More Information

What kind of information would you like to request?     More Information       Make a Referral

Leave this field empty

Many patients with depression do not respond effectively to first line antidepressant treatments, and for those who do respond it usually takes at least 3 weeks from the time of starting treatment to see any clinical benefit. Mayo Clinic is eager to find and develop promising new ways to diagnose and treat treatment-resistant depression. Dr. Susannah Tye, a researcher within the Mayo Clinic Department of Psychiatry and Psychology, discusses research on optimizing depression treatment with ketamine intervention for patients with treatment-resistant depression.

Comments